<DOC>
	<DOCNO>NCT01946672</DOCNO>
	<brief_summary>The purpose study evaluate feasibility isotopic technique identify , map lower-limb drainage node pelvic lymphadenectomy gynaecological cancer . The diagnostic value map method assess , determine incidence lymhedema .</brief_summary>
	<brief_title>Lower-Limb Drainage Mapping Pelvic Lymphadenectomy Gynaecological Cancer</brief_title>
	<detailed_description>Pelvic lymphadenectomy associate significant risk lower-limb lymphedema . In study , evaluate feasibility identify lower-limb drainage node ( LLDNs ) pelvic lymphadenectomy gynaecological cancer use isotopic detection technique preoperative radiopharmaceutical injection foot Secondary objective map lower-limb drainage , assess diagnostic value mapping technique , determine incidence lymphedema . LLDN mapping may allow preservation LLDNs , thereby decrease risk lower-limb lymphedema improve quality life .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Female patient 18 year age old indication pelvic lymphadenectomy gynaecological malignancy : High risk endometrial cancer ( stage IB type I grade 3 , stage I type II , stage &gt; IB ) metastatic sentinel lymph node , Early cervical cancer , metastatic sentinel lymph node , Ovarian cancer . Must provide sign informed consent Beneficiary health insurance Having receive medical examination Contraindication pelvic lymphadenectomy Presence lymphedema lower limbs Contraindication radiomarkers ( allergy hypersensitivity component biomarker ) Patient dementia alter mental status Pregnant breast feeding patient Participation clinical trial could interfere study result</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>gynaecological malignancy</keyword>
	<keyword>pelvic lymphadenectomy</keyword>
	<keyword>lymphedema</keyword>
	<keyword>sentinel node</keyword>
	<keyword>reverse mapping</keyword>
</DOC>